Skip to main content
. 2023 Apr 11;2023(4):CD013873. doi: 10.1002/14651858.CD013873.pub2

1.2. Analysis.

1.2

Comparison 1: High‐ versus standard‐dose strategies for any indication, Outcome 2: Major neurodevelopmental disability in children aged three to five years